Hot Pursuit     04-May-23
Natco Pharma Ltd spurts 2.15%, rises for fifth straight session
Natco Pharma Ltd is quoting at Rs 597.2, up 2.15% on the day as on 12:44 IST on the NSE. The stock is down 23.52% in last one year as compared to a 8.94% fall in NIFTY and a 2.73% fall in the Nifty Metal.

Natco Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 597.2, up 2.15% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.46% on the day, quoting at 18173.9. The Sensex is at 61476.67, up 0.46%. Natco Pharma Ltd has added around 3.34% in last one month.

Meanwhile, Nifty Metal index of which Natco Pharma Ltd is a constituent, has added around 3.87% in last one month and is currently quoting at 12586.8, up 0.53% on the day. The volume in the stock stood at 3.58 lakh shares today, compared to the daily average of 2.74 lakh shares in last one month.

The PE of the stock is 33.15 based on TTM earnings ending December 22.

Previous News
  Natco Pharma Ltd soars 3.1%, gains for fifth straight session
 ( Hot Pursuit - 19-Feb-24   13:00 )
  Natco Pharma announces resignation of senior management
 ( Corporate News - 15-Nov-23   14:16 )
  Natco Pharma reports consolidated net loss of Rs 50.50 crore in the March 2022 quarter
 ( Results - Announcements 30-May-22   16:51 )
  Natco Pharma Ltd soars 1.38%
 ( Hot Pursuit - 15-Feb-24   13:05 )
  Natco launches first generic version of Nexavar® (Sorafenib) Tablets in US market
 ( Corporate News - 01-Jun-22   09:57 )
  Board of Natco Pharma recommends Interim Dividend
 ( Corporate News - 10-Aug-23   11:24 )
  NATCO Pharma announces launch of Everolimus Tablets in U.S. market
 ( Corporate News - 18-Nov-21   17:28 )
  Natco Pharma Ltd spurts 0.67%, gains for fifth straight session
 ( Hot Pursuit - 03-Jan-24   13:00 )
  Natco Pharma receives USFDA approval for Carfilzomib Vials ANDA
 ( Corporate News - 14-Jun-21   12:56 )
  Natco Pharma receives registration approval for Chlorantraniliprole (CTPR)
 ( Corporate News - 05-Feb-21   10:52 )
  Natco Pharma (Canada) launches PrNAT-LENALIDOMIDE Capsules
 ( Corporate News - 02-Sep-21   10:04 )
Other Stories
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
Back Top